Galectin-3 is increasingly recognized as a potentially important diagnostic or prognostic biomarker for a variety of inflammatory and fibrotic diseases19–21 and has been found to be elevated in patients with idiopathic pulmonary fibrosis22,23 and more recently in COVID-19 patients24,25. This evidence concerns the gene LGALS3 and COVID-19.